Rondo Therapeutics

Cancer biotech Rondo gets $67M to step on the gas with next-gen bispecific drugs
MedCity News
Fri, 03/4/22 - 09:38 am
Rondo Therapeutics
bispecific antibodies
solid tumors
cancer
funding